Breaking News Instant updates and real-time market news.

SLDB

Solid Biosciences

$25.37

-0.29 (-1.13%)

, GOOS

Canada Goose

$57.76

-0.64 (-1.10%)

10:37
12/10/18
12/10
10:37
12/10/18
10:37

On The Fly: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Solid Biosciences (SLDB) initiated with a Neutral at BTIG. 2. Canada Goose (GOOS) initiated with a Positive at Susquehanna. 3. Internap (INAP) initiated with a Buy at Jefferies. 4. Vapotherm (VAPO) initiated with an Outperform at William Blair and a Buy at BTIG, Canaccord, and BofA/Merrill. 5. Gold Fields (GFI) initiated with an Underperform at BMO Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

SLDB

Solid Biosciences

$25.37

-0.29 (-1.13%)

GOOS

Canada Goose

$57.76

-0.64 (-1.10%)

INAP

Internap

$5.50

0.21 (3.97%)

VAPO

Vapotherm

$20.75

(0.00%)

GFI

Gold Fields

$3.09

-0.09 (-2.83%)

SLDB Solid Biosciences
$25.37

-0.29 (-1.13%)

12/10/18
BTIG
12/10/18
INITIATION
BTIG
Neutral
Solid Biosciences initiated with a Neutral at BTIG
BTIG analyst Timothy Chiang initiated Solid Biosciences with a Neutral rating. The analyst notes that the company is one of three players with a micro-dystrophin gene therapy for the treatment of Duchenne Muscular Dystrophy, or DMD, but also does not expect that program to gain approval until 2022. Chiang further states that he anticipates the peak sales potential for gene therapies for DMD to take place in 2024-2025 and believes that the current valuation on Solid Biosciences reflects those expectations.
09/06/18
FBCO
09/06/18
INITIATION
Target $38
FBCO
Neutral
Solid Biosciences initiated with a Neutral at Credit Suisse
Credit Suisse analyst Martin Auster started Solid Biosciences with a Neutral rating and $38 price target. The analyst notes that the company's DMD gene therapy, SGT-001, has clear mechanistic rationale and is well supported by preclinical proof-of-concept. Auster anticipates clinical differentiation, time to market, and durability will be among the most meaningful arbiters of value among the three clinical stage DMD gene therapy products and expects longer term data to refine his thinking and modeling assumptions.
11/06/18
SBSH
11/06/18
INITIATION
Target $25
SBSH
Sell
Solid Biosciences initiated with a Sell at Citi
Citi analyst Joel Beatty started Solid Biosciences (SLDB) with a Sell rating and $25 price target. The analyst believes the gene therapy agents in clinical development for Duchenne muscular dystrophy by Sarepta (SRPT) and Pfizer (PFE) will leave little market share to Solid Bio's SGT-001. The analyst forecasts Sarepta capturing the largest share of the DMD gene therapy market, followed by Pfizer, and then Solid.
12/03/18
SBSH
12/03/18
NO CHANGE
Target $31
SBSH
Sell
Solid Biosciences price target raised to $31 from $25 at Citi
Citi analyst Joel Beatty raised his price target for Solid Biosciences to $31 after the company successfully dosed two additional patients "without an additional clinical hold or a major safety event." The analyst, however, keeps a Sell rating on the shares. He continues to believe Solid will have to dose escalate twice more to reach a commercially competitive dose.
GOOS Canada Goose
$57.76

-0.64 (-1.10%)

12/10/18
SUSQ
12/10/18
INITIATION
SUSQ
Positive
Canada Goose initiated with a Positive at Susquehanna
Susquehanna analyst Sam Poser started Canada Goose Holdings with a Positive rating and C$98 price target. The analyst views Canada Goose as the "best-in-class, luxury, aspirational cold weather brand steeped in heritage, with significant growth potential." He believes the company is positioned as "THE" luxury winter performance outdoor apparel brand and recommends buying the shares at current levels.
11/15/18
DADA
11/15/18
NO CHANGE
Target $74
DADA
Buy
Canada Goose price target raised to $74 from $68 at DA Davidson
DA Davidson analyst John Morris raised his price target on Canada Goose to $74 after its Q2 earnings beat, saying the "impressive results" came from the company's "off-season store productivity, the build-out of their Greater China business, and wholesale channel growth". The analyst notes that the company's Baffin acquisition also offers "category expansion opportunities and brand value through versatility and fashion". Morris keeps his Buy rating on Canada Goose and raises his FY19 EPS view to $1.04 from 86c and FY20 view to $1.41 from $1.19 after its "above-plan performance".
11/15/18
ADAM
11/15/18
NO CHANGE
ADAM
Buy
Canada Goose price target raised to C$102 from C$91 at Canaccord
Canaccord analyst Camilo Lyon raised his price target on Canada Goose to C$102 from C$91 following solid Q2 results. He called the report a high quality beat with all the key metrics making a contribution. He said the remarkable growth benefited from management's flawless execution and ongoing momentum in the business. Lyon reiterated his Buy rating on Canada Goose shares.
11/15/18
FBCO
11/15/18
NO CHANGE
Target $100
FBCO
Outperform
Canada Goose price target raised to $100 from $88 at Credit Suisse
Credit Suisse analyst Michael Binetti raised his price target for Canada Goose to $100 from $88, citing a "huge" Q2 beat, conservative guidance and significant margin upside. The analyst reiterates an Outperform rating on the shares.
INAP Internap
$5.50

0.21 (3.97%)

11/02/18
CHLM
11/02/18
NO CHANGE
Target $16
CHLM
Buy
Internap price target cut to $16 from $22 at Craig-Hallum
Craig-Hallum analyst George Sutton maintained a Buy rating on Internap but lowered his price target to $16 from $22 following the company's in-line results. In a research note to investors, Sutton says he believes the current pullback represents a great buying opportunity, citing a growing backlog that has yet to matriculate into reported results, incremental demand from existing customers and increased balance sheet flexibility resulting from their recent equity raise as key reasons to be bullish on the company.
11/02/18
RHCO
11/02/18
NO CHANGE
Target $15
RHCO
Buy
Internap price target lowered to $15 from $22 at SunTrust
SunTrust analyst Greg Miller lowered his price target on Internap to $15 after its in-line Q3 results, noting that while the company "positively surprised by announcing a colocation deal in Dallas, it simultaneously cut the mid-point of Q4 guidance range implying little to no sequential growth". The analyst notes that investors were likely disappointed, anticipating continued improvements close to the equity offering, but believes that the downdraft in the stock price was an over-reaction. Miller keeps his Buy rating on Internap, saying the "company is uniquely positioned with a portfolio of data center assets that are ripe for growth".
12/10/18
JEFF
12/10/18
INITIATION
Target $7.5
JEFF
Buy
Internap initiated with a Buy at Jefferies
Jefferies analyst Jonathan Petersen started Internap with a Buy rating and $7.50 price target.
12/10/18
JEFF
12/10/18
INITIATION
Target $7.5
JEFF
Buy
Jefferies says Internap portfolio improved and undervalued, starts with Buy
Jefferies analyst Jonathan Petersen initiated coverage of Internap with a Buy rating and $7.50 price target. Trading at 6.8 times EBITDA, the market is penalizing the company for its high leverage, but undervaluing its improved portfolio with growing EBITDA, Petersen tells investors in a research note. He believes Internap's below average utilization provides an opportunity to drive revenue growth with lower incremental capex needs.
VAPO Vapotherm
$20.75

(0.00%)

12/10/18
ADAM
12/10/18
INITIATION
Target $25
ADAM
Buy
Vapotherm initiated with a Buy at Canaccord
Canaccord analyst Jason Mills initiated Vapotherm with a Buy rating and $25 price target. In a research note to investors, Mills says Vapotherm is actively disrupting the large market associated with patients in acute respiratory distress with its novel, non-invasive Hi-VNI therapy, which he believes could eventually become the standard-of-care treatment for patients experiencing undifferentiated respiratory distress. Vapotherm is a compelling growth story, Mills contends, and sees the company positioned to deliver "strong" double digit sales growth over the long term above its small-cap med-tech peer group.
12/10/18
BOFA
12/10/18
INITIATION
Target $26
BOFA
Buy
Vapotherm initiated with a Buy at BofA/Merrill
BofA/Merrill analyst Bob Hopkins initiated Vapotherm with a Buy and $26 price target.
12/10/18
WBLR
12/10/18
INITIATION
WBLR
Outperform
William Blair starts Vapotherm at Outperform, sees 15%-20% sales growth
William Blair analyst Margaret Kaczor initiated coverage of Vapotherm with an Outperform rating. The company's Precision Flow system with Hi-VNI Technology is a unique device used to treat patients in acute respiratory distress, Kaczor tells investors in a research note. The analyst believes that as the only mask-free technology validated as equivalent to standard of care for patients with spontaneous breathing, adoption should accelerate. She estimates over 12M patients annually can benefit from the clinical and economic advantages of the device, representing a $1.5B addressable market that is less than 5% penetrated today. Kaczor sees 15%-20% revenue growth for Vapotherm over the next three years.
12/10/18
BTIG
12/10/18
INITIATION
Target $26
BTIG
Buy
Vapotherm initiated with a Buy at BTIG
BTIG analyst Sean Lavin initiated Vapotherm with a Buy rating and a price target of $26. The analyst believes that the company's Precision Flow system of humidified oxygen delivery in respiratory support for patients works "as well or better than the standard of care, with additional comfort, workload and cost benefits." Lavin anticipates Vapotherm revenue to grow by about 20% per year through 2021 and sees its high-velocity nasal insufflation technology having "the right ingredients for successful adoption.
GFI Gold Fields
$3.09

-0.09 (-2.83%)

12/10/18
BMOC
12/10/18
INITIATION
Target $3
BMOC
Underperform
Gold Fields initiated with an Underperform at BMO Capital
BMO Capital analyst Andrew Kaip initiated Gold Fields with an Underperform rating and a price target of $3. The analyst notes that while he likes the direction of the company toward portfolio management, he also sees more work to do on the reserve life fronts. Kaip further cites the company's continued exposure to South Africa, but adds that the resolution of strike activities and a "measurable operational progress on restructuring South Deep" would be the catalysts that would lead him to reconsider his rating.
09/18/18
RBCM
09/18/18
UPGRADE
RBCM
Outperform
Gold Fields upgraded to Outperform from Sector Perform at RBC Capital
RBC Capital analyst James Bell upgraded Gold Fields to Outperform from Sector Perform and raised his price target to ZAR5,000 from ZAR4,300. The analyst notes that the company's re-investment plan will yield a strong free cash flow inflection in 2019, adding that Gold Fields is also better positioned relative to its competitors based on its "underappreciated" Australia business. Bell further states that while the company's valuation discount relative to its EMEA peers has narrowed, it remains attractive with current multiples now at a 2-year low.
09/18/18
RBCM
09/18/18
DOWNGRADE
RBCM
Sector Perform
AngloGold downgraded to Sector Perform from Outperform at RBC Capital
RBC Capital analyst James Bell downgraded AngloGold (AU) to Sector Perform from Outperform and lowered his price target to ZAR13,000 from ZAR13,200. The analyst says the "large diversified gold miner business is under pressure" and needs to be addressed, but adds that the company's new CEO Kevin Dushinsky is up to the task. Bell adds that AngloGold's valuation is less attractive than some of its South Africa peers like Gold Fields (GFI).
08/17/18
HSBC
08/17/18
UPGRADE
HSBC
Buy
Gold Fields upgraded to Buy from Hold at HSBC

TODAY'S FREE FLY STORIES

20:20
11/21/19
11/21
20:20
11/21/19
20:20
General news
Treasury Market Summary »

Treasury Market Summary:…

LYV

Live Nation

$66.17

-1.55 (-2.29%)

20:08
11/21/19
11/21
20:08
11/21/19
20:08
Periodicals
Live Nation 'looking forward' to taking part in Congress review of ticket market 

Report from Bloomberg.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRH

DiamondRock

$9.86

-0.085 (-0.86%)

19:53
11/21/19
11/21
19:53
11/21/19
19:53
Upgrade
DiamondRock rating change at Wells Fargo »

DiamondRock upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OOMA

Ooma

$11.18

-0.01 (-0.09%)

, IIIV

i3 Verticals

$22.29

-0.52 (-2.28%)

19:18
11/21/19
11/21
19:18
11/21/19
19:18
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Ooma…

OOMA

Ooma

$11.18

-0.01 (-0.09%)

IIIV

i3 Verticals

$22.29

-0.52 (-2.28%)

JWN

Nordstrom

$34.29

0.35 (1.03%)

SCVL

Shoe Carnival

$37.18

1.36 (3.80%)

SPLK

Splunk

$126.80

-0.04 (-0.03%)

GPS

Gap

$16.22

-0.05 (-0.31%)

ROST

Ross Stores

$111.81

1.39 (1.26%)

PSTG

Pure Storage

$19.84

-0.22 (-1.10%)

WSM

Williams-Sonoma

$68.76

0.195 (0.28%)

PNNT

PennantPark

$5.95

0.01 (0.17%)

ENTA

Enanta

$63.27

1.55 (2.51%)

INTU

Intuit

$270.01

-3.38 (-1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 22

    Nov

  • 22

    Nov

  • 02

    Dec

  • 02

    Dec

  • 03

    Dec

  • 05

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 12

    Dec

  • 10

    Mar

  • 11

    Mar

AES

AES Corp.

$18.50

-0.115 (-0.62%)

19:08
11/21/19
11/21
19:08
11/21/19
19:08
Earnings
AES backs FY19 adjusted EPS view $1.30-$1.38, consensus $1.33 »

The company also…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

WM

Waste Management

$111.23

-1.305 (-1.16%)

, RSG

Republic Services

$86.78

-0.91 (-1.04%)

19:07
11/21/19
11/21
19:07
11/21/19
19:07
Initiation
Waste Management, Republic Services, Waste Connections, Clean Harbors, Stericycle, Casella Waste, Covanta initiated  »

Jefferies initiates…

WM

Waste Management

$111.23

-1.305 (-1.16%)

RSG

Republic Services

$86.78

-0.91 (-1.04%)

WCN

Waste Connections

$89.54

-0.28 (-0.31%)

CLH

Clean Harbors

$84.70

-0.75 (-0.88%)

SRCL

Stericycle

$62.49

0.76 (1.23%)

CWST

Casella Waste

$43.70

-0.39 (-0.88%)

CVA

Covanta

$14.43

-0.14 (-0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AES

AES Corp.

$18.50

-0.115 (-0.62%)

19:07
11/21/19
11/21
19:07
11/21/19
19:07
Hot Stocks
AES Corp. says PUCO has modified DP&L rates »

The AES Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

ICE

IntercontinentalExchange

$93.89

-0.58 (-0.61%)

, BTC

Bitcoin

$0.00

(0.00%)

19:02
11/21/19
11/21
19:02
11/21/19
19:02
Hot Stocks
ICE announces launch of Bakkt Bitcoin Cash Settled Monthly Futures contract »

Intercontinental Exchange…

ICE

IntercontinentalExchange

$93.89

-0.58 (-0.61%)

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAN

ManpowerGroup

$92.05

-0.355 (-0.38%)

18:51
11/21/19
11/21
18:51
11/21/19
18:51
Initiation
ManpowerGroup initiated at Jefferies »

ManpowerGroup initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHI

Robert Half

$58.01

-0.38 (-0.65%)

18:48
11/21/19
11/21
18:48
11/21/19
18:48
Initiation
Robert Half initiated at Jefferies »

Robert Half initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HTZ

Hertz

$15.37

0.265 (1.76%)

18:46
11/21/19
11/21
18:46
11/21/19
18:46
Initiation
Hertz initiated at Jefferies »

Hertz initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAR

Avis Budget

$28.71

0.16 (0.56%)

18:44
11/21/19
11/21
18:44
11/21/19
18:44
Initiation
Avis Budget initiated at Jefferies »

Avis Budget initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMD

AMD

$39.52

-1.45 (-3.54%)

18:42
11/21/19
11/21
18:42
11/21/19
18:42
Hot Stocks
AMD CEO: The key for us is product generation »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 12

    Dec

CTAS

Cintas

$253.61

-5.78 (-2.23%)

, BFAM

Bright Horizons

$148.62

-3.92 (-2.57%)

18:42
11/21/19
11/21
18:42
11/21/19
18:42
Initiation
Cintas, Bright Horizons, Aramark, H&R Block, BrightView, Rollins, ServiceMaster initiated at Jefferies »

Jefferies initiates…

CTAS

Cintas

$253.61

-5.78 (-2.23%)

BFAM

Bright Horizons

$148.62

-3.92 (-2.57%)

ARMK

Aramark

$42.42

-1.37 (-3.13%)

HRB

H&R Block

$24.34

-0.15 (-0.61%)

BV

BrightView

$16.79

-2.525 (-13.08%)

ROL

Rollins

$35.77

-0.8 (-2.19%)

SERV

ServiceMaster

$36.16

-0.42 (-1.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 04

    Dec

PINE

Alpine Income Properties

$0.00

(0.00%)

18:34
11/21/19
11/21
18:34
11/21/19
18:34
Syndicate
Alpine Income Properties 7.5M share IPO priced at $19.00 »

The deal priced at low…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

OTTW

Ottawa Bancorp

$13.39

-0.39 (-2.83%)

18:28
11/21/19
11/21
18:28
11/21/19
18:28
Hot Stocks
Ottawa Bancorp approves stock buyback of 317,307 shares »

Ottawa Bancorp announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$149.46

-0.14 (-0.09%)

18:27
11/21/19
11/21
18:27
11/21/19
18:27
Periodicals
Microsoft says granted U.S. license to do business with Huawei, Bloomberg says »

Microsoft said it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 04

    Dec

  • 09

    Dec

SITC

Site Centers

$14.28

-0.275 (-1.89%)

18:24
11/21/19
11/21
18:24
11/21/19
18:24
Upgrade
Site Centers rating change at Stifel »

Site Centers upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Airlines

$90.96

-0.72 (-0.79%)

, BA

Boeing

$366.47

-4.275 (-1.15%)

18:23
11/21/19
11/21
18:23
11/21/19
18:23
Hot Stocks
United Airlines CEO: We don't think we are near a recession »

In an interview on…

UAL

United Airlines

$90.96

-0.72 (-0.79%)

BA

Boeing

$366.47

-4.275 (-1.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

FAST

Fastenal

$35.15

-0.1 (-0.28%)

, GWW

Grainger

$312.66

0.305 (0.10%)

18:20
11/21/19
11/21
18:20
11/21/19
18:20
Initiation
Fastenal, Grainger, HD Supply, MSC Industrial, Wesco initiated at Jefferies »

Jefferies initiates…

FAST

Fastenal

$35.15

-0.1 (-0.28%)

GWW

Grainger

$312.66

0.305 (0.10%)

HDS

HD Supply

$39.10

-0.21 (-0.53%)

MSM

MSC Industrial

$73.66

-0.125 (-0.17%)

WCC

Wesco

$53.09

-0.02 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 30

    Jan

SPGI

S&P Global

$264.34

-3.6 (-1.34%)

, INFO

IHS Markit

$71.62

-0.38 (-0.53%)

18:06
11/21/19
11/21
18:06
11/21/19
18:06
Initiation
S&P Global, IHS Markit, Verisk Analytics, Gartner, FactSet, Equifax, TransUnion, CoStar Group initiated at Jefferies »

Jefferies initiates…

SPGI

S&P Global

$264.34

-3.6 (-1.34%)

INFO

IHS Markit

$71.62

-0.38 (-0.53%)

VRSK

Verisk Analytics

$144.45

0.12 (0.08%)

IT

Gartner

$158.00

0.06 (0.04%)

FDS

FactSet

$258.20

-3.65 (-1.39%)

EFX

Equifax

$137.97

-1.15 (-0.83%)

TRU

TransUnion

$84.90

-1.34 (-1.55%)

CSGP

CoStar Group

$587.66

-7.45 (-1.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 19

    Dec

  • 19

    Dec

  • 07

    Jan

GPS

Gap

$16.22

-0.05 (-0.31%)

17:59
11/21/19
11/21
17:59
11/21/19
17:59
Periodicals
Gap to pull Old Navy brand from China in early 2020, Reuters reports »

Gap said it does not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 05

    Dec

LB

L Brands

$17.18

1.78 (11.56%)

17:50
11/21/19
11/21
17:50
11/21/19
17:50
Hot Stocks
L Brands cancels Victoria's Secret Fashion Show for 'more current platforms' »

The CFO of L Brands,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 05

    Dec

  • 27

    Feb

WCC

Wesco

$53.09

-0.02 (-0.04%)

17:47
11/21/19
11/21
17:47
11/21/19
17:47
Initiation
Wesco initiated at Jefferies »

Wesco initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAN

ManpowerGroup

$92.05

-0.355 (-0.38%)

17:47
11/21/19
11/21
17:47
11/21/19
17:47
Initiation
ManpowerGroup initiated at Jefferies »

ManpowerGroup initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.